8-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15 (d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

February 8, 2007

FMC CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	1-2376	94-0479804
(State or other jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1735 Market Street, Philadelphia, PA 19103

(Address of principal executive offices) (Zip Code)

(215) 299-6000

Registrant’s telephone number, including area code

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

q Written communications pursuant to Rule 425 under the Securities Act

q Soliciting material pursuant to Rule 14a-2 under the Exchange Act

q Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

q Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

ITEM 7.01. Regulation FD Disclosure.

On February 8, 2007, William G. Walter, Chairman, President and Chief Executive Officer, addressed a group of investors at the Chemical Analysts of New York meeting in New York, NY. Slides used in his presentation at the meeting are included hereto as an exhibit. These slides may also be accessed at the company’s website (www.fmc.com) and will be available for a period of at least thirty days.

This report is not deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.

ITEM 9.01. Financial Statements and Exhibits

(d) Exhibits.

99.1 FMC presentation by William G. Walter at the Chemical Analysts of New York meeting in New York, NY, on February 8, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

FMC CORPORATION
By:	/s/ W. KIM FOSTER
	W. Kim Foster Senior Vice President and Chief Financial Officer

Date: February 8, 2007

EXHIBIT INDEX

Exhibit Number	Description
99.1	FMC presentation by William G. Walter at the Chemical Analysts of New York meeting in New York, NY, on February 8, 2007.

EX-99.1

FMC Corporation

William G. Walter

Chairman, President and CEO

New York, NY

February 8, 2007

Exhibit 99.1

#

#

#

1

Disclaimer

Safe Harbor Statement under the

Private Securities Litigation Reform Act of 1995

•

These slides and the accompanying presentation contain “forward-looking

statements”

that represent management’s best judgment as of the date hereof

based on

information

currently

available.

Actual

results

of

the

Company

may

differ materially from those contained in the forward-looking statements. 

•

Additional information

concerning

factors

that

may

cause

results

to

differ

materially from those in the forward-looking statements is contained in the

Company’s periodic reports filed under the Securities Exchange Act of 1934, as

amended.

•

The Company undertakes no obligation to update or revise these forward-

looking statements to reflect new events or uncertainties.

Non-GAAP Financial Terms

•

These slides

contain

certain

“non-GAAP

financial

terms”

which

are

defined

in

the appendix.  In addition, we have provided reconciliations of non-GAAP terms

to the closest GAAP term in the appendix.

2

FMC Corporation

For the FY ending December 31, 2006 ($ millions)

FMC

Revenue:

$2,347.0

EBITDA:

$455.0

Margin*:

19.4%

Industrial

Chemicals

Revenue:

$990.9

EBITDA:

$161.2

Margin*:

16.3%

Agricultural

Products

Revenue: 

$767.0

EBITDA:

$182.4

Margin*:

23.8%

Specialty

Chemicals

Revenue:

$592.8

EBITDA:

$150.1

Margin*:

25.3%

*

EBITDA margin

Leading Market Positions

Greater than 80% of Sales in Non-GDP Cyclical Markets

Backward Integration and Global Sourcing

Limited Dependence on Petrochemical Feedstocks

3

Performance in 2006

($ millions, expect per share data)

$

% v. PY

$

% v. PY

FMC Sales

588.4

13

2,347.0

9

FMC EPS

(1)

1.24

15

5.48

25

Operating Income

(2)

Agricultural Products

23.2

15

151.0

21

Specialty Chemicals

24.5

7

118.8

10

Industrial Chemicals

21.2

8

96.7

15

(1)

Earnings before restructuring and other charges

(2)

Income from continuing operations before income taxes

4Q06

FY 2006

4

Realizing the inherent operating leverage within FMC

-

Sustained

trend

line

earnings

growth

>10%

per

year

(1)

-

Fourth year of recovery in Industrial Chemicals

-

Continued growth in Specialty Chemicals and Agricultural Products

Maintaining financial strength and flexibility

-

Investing in higher growth businesses

-

Pursuing external growth opportunities

-

Returning cash to shareholders –

dividend and share repurchase

Focusing the portfolio on higher growth businesses

-

Managing Specialty Chemicals and Agricultural Products for growth

-

Managing Industrial Chemicals for cash

Disciplined Approach to Unlocking Value

(1)

Earnings before restructuring and other income and charges

5

Agricultural Products

Strong niche positions in the Americas, Europe and Asia

Proprietary, branded insecticides and herbicides

FMC differentiated by:

–

Focused strategy in selected products, crops and regions

–

Shifting primary paradigm to shorter innovation cycle

–

Joint ventures, alliances and in-licensing

–

Global supply chain productivity improvements

Insecticides

73%

North America

28%

Latin America

39%

Asia

16%

Europe/

Middle

East/Africa

17%

Herbicides

25%

Fungicides 2%

Based on 2005 Consolidated Sales

6

BioPolymer

69%

Lithium

31%

Latin

America

6%

North America

39%

Europe/Middle

East/Africa

37%

Asia

18%

•

One of two global, integrated manufacturers

•

Focus on specialty products –

pharmaceuticals and

energy storage devices

Lithium:

•

Adds structure, texture and stability to food

•

Acts as a binder & disintegrant for dry tablet drugs

•

Market leader in every product line

BioPolymer:

Specialty Chemicals

Based on 2005 Consolidated Sales

7

Industrial Chemicals

Pursuing near-term sales growth thru higher volumes and prices

Working to

offset

higher

energy,

raw

material

and

transportation

costs

Favorable soda ash market conditions

Near-term energy situation in Spain

Asia

7%

Alkali

(Soda ash)

49%

Peroxygens

18%

Foret

33%

Latin

America

9%

North America

50%

Europe/Middle

East/Africa

34%

Asia

7%

Based on 2005 Consolidated Sales

8

FMC in Summary

Great businesses, each with EBITDA of at least $150 million

Double-digit trend line earnings growth

-

Earnings leverage in Industrial Chemicals

-

Continued growth in Specialty Chemicals and Ag Products

Strategic and financial flexibility

-

Robust and growing EBITDA

-

Recent balance sheet de-leveraging

-

Low capex requirements

Disciplined approach to unlocking value

FMC Corporation

#

#

10

Non-GAAP Financial Terms

These slides contain certain “non-GAAP financial terms”

which are defined

below. In addition, we have provided reconciliations of non-GAAP terms to

the closest GAAP term in the appendix of this presentation.

EBITDA

(Earnings Before Interest, Taxes, Depreciation and Amortization)

is the

sum

of Income (loss) from continuing operations before income taxes

and

Depreciation and Amortization.

EBITDA

Margin

is

the

quotient

of

EBITDA

(defined

above)

divided

by

Revenue.

ROIC

(Return

on

Invested

Capital)

is

the

sum

of

Earnings

from

continuing

operations before restructuring and other income and charges

and after-tax

Interest expense

divided by the sum

of Short-term debt, Current portion of

long-term debt, Long-term debt

and Total shareholders’

equity.

11

Segment Financial Terms

These slides

contain

references

to

segment

financial

items

which

are

presented in detail in Note 18 of FMC’s 2005 Form 10-K.  Some of the

segment financial terms are “non-GAAP financial terms”

and are defined

below. In addition, we have provided reconciliations of non-GAAP terms to

the closest GAAP term in the appendix of this presentation. 

EBITDA

(Earnings Before Interest, Taxes, Depreciation and Amortization)

for a segment

is the

sum

of Income (loss) from continuing operations

before

income

taxes

for

that

segment

and

Depreciation

and

Amortization

for that segment.

EBITDA

Margin

for

a

segment

is

the

quotient

of

EBITDA

(defined

above)

divided

by Revenue

for that segment.

12

Reconciliation

of

Fiscal

Year

2006

consolidated

income

from

continuing

operations

before

income

taxes

(a

GAAP

measure)

to

Fiscal

Year

2006

EBITDA

(a

Non-GAAP

measure

(Unaudited, in $ millions)

FY 2006

Income from continuing operations before

income taxes

$213.5

Add:

Restructuring and other charges

74.8

EBITDA Reconciliation: FY 2006

Interest expense, net

32.9

Depreciation and amortization

131.8

EBITDA (Non-GAAP)

$455.0

In process research and development

2.0

13

Reconciliation

of

Fiscal

Year

2006

segment

operating

profit

(a

GAAP

measure)

To

Fiscal

Year

2006

EBITDA

(a

Non-GAAP

measure)

(Unaudited, in millions)

Industrial

Specialty

Agricultural

Segment

Chemicals

Chemicals

Products

FY 2006 segment operating profit (GAAP)

$96.7

$118.8

$151.0

Add:

Depreciation and amortization

64.5

31.3

31.4

FY 2006  EBITDA (Non-GAAP)

$161.2

$150.1

$182.4

Segment EBITDA Reconciliation